Payment overview · 2025
General Payments
$693.19
14 reported records · 1 companies
Healthcare provider profile · identity verified
Walter Wallace Johnson, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · CHARLOTTE, NC · NPI 1093798225
Verified facts
What the public records show
CMS Open Payments records show Walter Wallace Johnson, M.D. received $693.19 in general payments during 2025 across 14 reported records.
Abbott Laboratories accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 4 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Abbott Laboratories | Unresolved — no canonical attribution shown | $693.19 | 100.0% | 14 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $693.19 | 14 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| ETERNA Normalized: eterna |
Device | Abbott Laboratories | $645.08 | 10 | 2025 |
Source payment records
|
|||||
| FREESTYLE LIBRE 3 Normalized: freestyle libre 3 |
Device | Abbott Laboratories | $22.29 | 1 | 2025 |
Source payment records
|
|||||
| PROCLAIM Normalized: proclaim |
Device | Abbott Laboratories | $15.94 | 2 | 2025 |
Source payment records
|
|||||
| AXIUM Normalized: axium |
Device | Abbott Laboratories | $9.88 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Amlodipine Besylate | Amlodipine Besylate | 599 | 164 |
| Atorvastatin Calcium | Atorvastatin Calcium | 368 | 97 |
| Simvastatin | Simvastatin | 277 | 76 |
| Losartan Potassium | Losartan Potassium | 247 | 62 |
| Omeprazole | Omeprazole | 242 | 70 |
| Gabapentin | Gabapentin | 214 | 46 |
| Hydrochlorothiazide | Hydrochlorothiazide | 213 | 67 |
| Metformin Hcl | Metformin Hcl | 207 | 58 |
| Metoprolol Succinate | Metoprolol Succinate | 177 | 46 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 168 | 51 |
| Levothyroxine Sodium | Levothyroxine Sodium | 158 | 45 |
| Pantoprazole Sodium | Pantoprazole Sodium | 153 | 42 |
| Tamsulosin Hcl | Tamsulosin Hcl | 152 | 46 |
| Lisinopril | Lisinopril | 128 | 36 |
| Pravastatin Sodium | Pravastatin Sodium | 123 | 45 |
| Fluticasone Propionate | Fluticasone Propionate | 121 | 47 |
| Furosemide | Furosemide | 121 | 39 |
| Metformin Hcl Er | Metformin Hcl | 110 | 29 |
| Allopurinol | Allopurinol | 108 | 28 |
| Metoprolol Tartrate | Metoprolol Tartrate | 91 | 28 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 85 | 33 |
| Carvedilol | Carvedilol | 81 | 24 |
| Glimepiride | Glimepiride | 81 | 20 |
| Eliquis | Apixaban | 78 | 19 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 71 | suppressed |
| Ezetimibe | Ezetimibe | 70 | 22 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 70 | 19 |
| Meloxicam | Meloxicam | 68 | 22 |
| Famotidine | Famotidine | 63 | 22 |
| Azelastine Hcl | Azelastine Hcl | 62 | 15 |
| Benazepril Hcl | Benazepril Hcl | 62 | 16 |
| Duloxetine Hcl | Duloxetine Hcl | 58 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 57 | 17 |
| Clopidogrel | Clopidogrel Bisulfate | 56 | 16 |
| Tramadol Hcl | Tramadol Hcl | 55 | 18 |
| Hydralazine Hcl | Hydralazine Hcl | 53 | 15 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 52 | 13 |
| Pregabalin | Pregabalin | 46 | suppressed |
| Sertraline Hcl | Sertraline Hcl | 46 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 45 | 12 |
| Citalopram Hbr | Citalopram Hydrobromide | 44 | 12 |
| Ibuprofen | Ibuprofen | 44 | 12 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 44 | 14 |
| Montelukast Sodium | Montelukast Sodium | 44 | 13 |
| Potassium Chloride | Potassium Chloride | 44 | 15 |
| Valsartan | Valsartan | 44 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 42 | 12 |
| Glipizide Er | Glipizide | 40 | suppressed |
| Mounjaro | Tirzepatide | 40 | suppressed |
| Nifedipine Er | Nifedipine | 40 | suppressed |
| Jardiance | Empagliflozin | 39 | suppressed |
| Methylprednisolone | Methylprednisolone | 39 | 33 |
| Quetiapine Fumarate | Quetiapine Fumarate | 39 | suppressed |
| Trazodone Hcl | Trazodone Hcl | 39 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 38 | suppressed |
| Januvia | Sitagliptin Phosphate | 36 | 12 |
| Pioglitazone Hcl | Pioglitazone Hcl | 36 | suppressed |
| Lorazepam | Lorazepam | 34 | suppressed |
| Sucralfate | Sucralfate | 33 | 11 |
| Synthroid | Levothyroxine Sodium | 33 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 32 | 12 |
| Ramipril | Ramipril | 32 | suppressed |
| Clonazepam | Clonazepam | 31 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 31 | suppressed |
| Telmisartan | Telmisartan | 31 | suppressed |
| Ozempic | Semaglutide | 30 | suppressed |
| Atenolol | Atenolol | 27 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 27 | 11 |
| Finasteride | Finasteride | 27 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 27 | 15 |
| Glipizide | Glipizide | 25 | suppressed |
| Spironolactone | Spironolactone | 25 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 24 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 23 | 11 |
| Promethazine Hcl | Promethazine Hcl | 23 | suppressed |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 22 | suppressed |
| Bupropion Xl | Bupropion Hcl | 22 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 22 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 22 | suppressed |
| Prednisone | Prednisone | 22 | 12 |
| Celecoxib | Celecoxib | 21 | suppressed |
| Colchicine | Colchicine | 21 | suppressed |
| Amlodipine-Olmesartan | Amlodipine Bes/Olmesartan Med | 20 | suppressed |
| Mirtazapine | Mirtazapine | 20 | suppressed |
| Latanoprost | Latanoprost | 19 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 19 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 18 | 12 |
| Zolpidem Tartrate | Zolpidem Tartrate | 18 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 17 | suppressed |
| Xarelto | Rivaroxaban | 17 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 16 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 16 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 15 | suppressed |
| Nystatin | Nystatin | 15 | suppressed |
| Verapamil Er | Verapamil Hcl | 15 | suppressed |
| Buprenorphine Hcl | Buprenorphine Hcl | 14 | suppressed |
| Cephalexin | Cephalexin | 14 | 11 |
| Entresto | Sacubitril/Valsartan | 14 | suppressed |
| Livalo | Pitavastatin Calcium | 14 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 14 | suppressed |
| Nitroglycerin | Nitroglycerin | 14 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 14 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 14 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 13 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 13 | suppressed |
| Oxycontin | Oxycodone Hcl | 13 | suppressed |
| Torsemide | Torsemide | 13 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 13 | suppressed |
| Trulicity | Dulaglutide | 13 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 13 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 13 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 12 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 12 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 12 | 11 |
| Diclofenac Sodium | Diclofenac Sodium | 12 | suppressed |
| Eszopiclone | Eszopiclone | 12 | suppressed |
| Lactulose | Lactulose | 12 | suppressed |
| Lidocaine | Lidocaine | 12 | suppressed |
| Olanzapine | Olanzapine | 12 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 12 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 12 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 12 | suppressed |
| Telmisartan-Hydrochlorothiazid | Telmisartan/Hydrochlorothiazid | 12 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 11 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 11 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 11 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 11 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 11 | suppressed |
| Novolog Flexpen | Insulin Aspart | 11 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 11 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 11 | suppressed |
| Veo Insulin Syringe | Syring-Needl,disp,insul,0.3 Ml | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $693.19 · 14 records | Abbott Laboratories | AXIUM, ETERNA, FREESTYLE LIBRE 3, PROCLAIM | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error